Business NewsPR NewsWire • Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China

Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China

Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China

SUZHOU, China, June 19, 2020 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today...

View More : https://www.prnewswire.com:443/news-releases/innovent-announces-the-nmpa-granted-marketing-approval-for-byvasda-bevacizu...
Releted News by prnewswire
Senseon (a Division of Accuride International) and Anixter International Announce Channel Partner Relationship to Create Comprehensive Security Solutions
Alight appuie les interventions de réfugiés du monde entier face à la COVID-19
Radiko Announces Management Cease Trade Order
Innovent Announces the NMPA Granted Marketing Approval for BYVASDA® (Bevacizumab Biosimilar) in China
NEXA Digital Marketing Agency Invests in UAE based Pipeline Business Growth Services to Create a Unique Lead Generation Service for Enterprise Clients in the MENA Region
Planned Parenthood of Greater New York Votes PAC Endorses Health Care Champions in Senate & Assembly Races
MasterClass Announces Legendary Skater Tony Hawk to Teach Skateboarding